Bayer Healthcare to gear up for Primovist, Nexavar comarketing

Published: 2009-09-16 06:56:00

Updated: 2009-09-16 06:56:00

Bayer Healthcare has strengthened its presence in the domestic liver market by copromoting its magnetic resonance imaging (MRI) contrast agent Primovist (gadoxetate disodium) for the detection and characterization of liver lesions and Nexavar, liver cancer drug, with a marketing campaign titled “...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK